Showing results (121-130 of 329) with videos related to
Sort By:
Pageof 33
The Journal of Pharmacy and Pharmacology|June 30, 2000
Mono- and biphasic plasma concentration-time curves of mesalazine from a 500 mg suppository in healthy male volunteers controlled by the time of defecation before dosingT B Vree, E Dammers, P S Exler, et al.Journal of Clinical Medicine|December 9, 2023
Remimazolam Pilot for Office-Based Dental Sedation: Adverse Events, Awareness and OutcomesRudi Swart, Sabine S A Maes, David Cavanaugh, et al.Ticks and Tick-Borne Diseases|September 13, 2023
Prevalence of five human pathogens in host-seeking Ixodes scapularis and Ixodes pacificus by region, state, and county in the contiguous United States generated through national tick surveillanceErik Foster, Sarah A Maes, Karen M Holcomb, et al.Biomedical & Environmental Mass Spectrometry|October 1, 1988
Why do doping control labs need a tandem mass spectrometer?E G de Jong, R A Maes, J M van RossumJournal of Chromatography. B, Biomedical Applications|January 6, 1995
Evaluation of the Salivette as sampling device for monitoring beta-adrenoceptor blocking drugs in salivaK M Höld, D de Boer, J Zuidema, et al.European Heart Journal|July 4, 1998
Segmental comparison between coronary angiography and positron emission tomography reveals low predictive value of epicardial flow for viabilityZ Koszegi, A Maes, J Piessens, et al.Nuklearmedizin. Nuclear Medicine|August 1, 1996
Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusionA R Wafelman, C A Hoefnagel, R A Maes, et al.European Journal of Nuclear Medicine|June 1, 1994
Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetryA R Wafelman, C A Hoefnagel, R A Maes, et al.Muscle & Nerve|September 19, 2012
Estimating electromyographic and heart rate fatigue thresholds from a single treadmill testDarren R Guffey, Bruno J Gervasi, Alex A Maes, et al.European Journal of Neurology|April 5, 2005
Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspectiveG Moulin-Romsee, A Maes, D Silverman, et al.Pageof 33